Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 56

1.

Is it time to say good bye to blow-by?

Restrepo RD.

Respir Care. 2012 Dec;57(12):2127-9. doi: 10.4187/respcare.02158. No abstract available.

2.

Blow-by as potential therapy for uncooperative children: an in-vitro study.

Mansour MM, Smaldone GC.

Respir Care. 2012 Dec;57(12):2004-11. doi: 10.4187/respcare.01653.

3.

Inhalation of aerosols by children: an ongoing controversy.

Schöni MH.

Swiss Med Wkly. 2004 Apr 3;134(13-14):173-4. No abstract available.

PMID:
15106030
4.

Herpetic blepharitis and inhaled budesonide.

Garcia-Medina JJ, del-Rio-Vellosillo M, Garcia-Medina M.

Ophthalmology. 2011 Dec;118(12):2520.e5-7. doi: 10.1016/j.ophtha.2011.07.054. No abstract available.

PMID:
22136691
6.

Strategy for the in vitro testing of spacers and holding chambers that may be used with young children.

Mitchell JP, Nagel MW.

J Aerosol Med. 1998;11 Suppl 1:S53-8. No abstract available.

PMID:
10180733
7.

Lung-to-systemic exposure ratio (L:S) calculation.

Harrison LI.

J Aerosol Med. 2001 Fall;14(3):377-8. No abstract available.

PMID:
11693850
8.

The output of budesonide from nebulizers.

Barry PW, O'Callaghan C.

J Allergy Clin Immunol. 1998 Aug;102(2):321-2. No abstract available.

PMID:
9723679
9.

Delivery options for inhaled therapy in children over the age of 6 years.

Pedersen S.

J Aerosol Med. 1997;10 Suppl 1:S41-4. No abstract available.

PMID:
10165123
10.
11.

Assessment of facial and ocular deposition of nebulized aerosol using a color-based method.

Kundoor V, Dalby RN.

Drug Dev Ind Pharm. 2010 Nov;36(11):1281-5. doi: 10.3109/03639041003753854.

PMID:
20545511
12.

Reality-based medicine.

Chapman KR.

Chest. 2000 Aug;118(2):281-3. No abstract available.

PMID:
10936109
13.

Delivery options for inhaled therapy in children under the age of 6 years.

Bisgaard H.

J Aerosol Med. 1997;10 Suppl 1:S37-40. No abstract available.

PMID:
10165122
14.
15.

A breath of fresh air for asthma patients.

[No authors listed]

Harv Womens Health Watch. 1998 Jan;5(5):7. No abstract available.

PMID:
9600041
16.

Possibility of ocular absorption of nebuliser aerosols.

Taylor RP.

Med J Aust. 1994 Nov 7;161(9):576. No abstract available.

PMID:
7968773
17.

Disposable versus reusable jet nebulizers for cystic fibrosis treatment with tobramycin.

Vecellio L, Abdelrahim ME, Montharu J, Galle J, Diot P, Dubus JC.

J Cyst Fibros. 2011 Mar;10(2):86-92. doi: 10.1016/j.jcf.2010.10.004.

18.

[Efficacy and safety of budesonide inhalation suspension nebulization by mesh nebulizer in Japanese infants and young children with bronchial asthma in 12-week, randomised, open study].

Tezuka J, Motomura C, Ikei J, Ide K, Kando N, Goto M, Taba N, Hayashi D, Murakami Y, Moriyasu Y, Soebijanto K, Shibata R, Okada K, Okada H, Nishima S.

Arerugi. 2008 Aug;57(8):1034-42. Japanese.

PMID:
18781108
19.

A double-blind, placebo-controlled steroid-sparing study with budesonide Turbuhaler in Japanese oral steroid-dependent asthma patients. Japanese Pulmicort Turbuhaler study group.

Miyamoto T, Takahashi T, Nakajima S, Makino S, Yamakido M, Mano K, Nakashima M, Tollemar U, Selroos O.

Respirology. 2000 Sep;5(3):231-40.

PMID:
11022985
20.

Deposition of small particles in the developing lung.

Amirav I, Newhouse MT.

Paediatr Respir Rev. 2012 Jun;13(2):73-8. doi: 10.1016/j.prrv.2011.05.006. Review.

PMID:
22475251
Items per page

Supplemental Content

Support Center